Adam Koppel Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Adam Koppel.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Adam Koppel. Adam Koppel is EVP, Strategy and Bus. Dev. in BIOGEN INC. ($IDPH) and SVP, Chief Strategy Officer in BIOGEN INC. ($IDPH) and Director in PTC THERAPEUTICS, INC. ($PTCT) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Director in TREVENA INC ($TRVN) and Director in Aptinyx Inc. ($APTX) and Director in Solid Biosciences Inc. ($SLDB) and Director in Cerevel Therapeutics Holdings, Inc. ($ARYB).

Latest Insider Trading Transactions of Adam Koppel

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, APTX, IDPH, CERE, DRNA, PTCT, SLDB, TRVN

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 05 2021	APTX	Aptinyx Inc.	Koppel Adam	Director	Option Exercise	A	3.46	5,508	19,058	5,508
Jan 05 2021	APTX	Aptinyx Inc.	Koppel Adam	Director	Option Exercise	A	3.46	5,508	19,058	5,508
Dec 14 2020	DRNA	Dicerna Pharmaceut ...	Koppel Adam	Director	Sell	S	23.40	1,000,000	23,400,000	3,080,237	4.1 M to 3.1 M (-24.51 %)
Dec 11 2020	SLDB	Solid Biosciences ...	Koppel Adam	Director	Grant	A	3.70	3,189,189	11,799,999	7,060,353	3.9 M to 7.1 M (+82.38 %)
Nov 12 2020	ARYB	Cerevel Therapeuti ...	Koppel Adam	Director	Buy	P	10.30	332,293	3,422,618	60,632,356	60.3 M to 60.6 M (+0.55 %)
Jun 18 2020	SLDB	Solid Biosciences ...	Koppel Adam	Director	Option Exercise	A	3.03	10,000	30,300	10,000
Jun 18 2020	SLDB	Solid Biosciences ...	Koppel Adam	Director	Option Exercise	A	3.03	30,000	90,900	30,000
Jun 16 2020	DRNA	Dicerna Pharmaceut ...	Koppel Adam	Director	Option Exercise	A	21.61	15,000	324,150	15,000
Jun 16 2020	DRNA	Dicerna Pharmaceut ...	Koppel Adam	Director	Option Exercise	A	0.00	3,333	0	3,333
Apr 02 2020	APTX	Aptinyx Inc.	Koppel Adam	Director	Option Exercise	A	2.16	8,296	17,919	8,296
Jan 16 2020	APTX	Aptinyx Inc.	Koppel Adam	Director	Buy	P	3.00	3,333,333	9,999,999	5,558,425	2.2 M to 5.6 M (+149.81 %)
Dec 06 2019	DRNA	Dicerna Pharmaceut ...	Koppel Adam	Director	Sell	S	24.68	1,500,000	37,020,000	4,080,237	5.6 M to 4.1 M (-26.88 %)
Jul 30 2019	SLDB	Solid Biosciences ...	Koppel Adam	Director	Grant	A	4.65	1,881,720	8,749,998	3,871,164	2 M to 3.9 M (+94.59 %)
Jun 21 2019	DRNA	Dicerna Pharmaceut ...	Koppel Adam	Director	Option Exercise	A	15.44	25,000	386,000	25,000
Jun 17 2019	SLDB	Solid Biosciences ...	Koppel Adam	Director	Option Exercise	A	5.26	10,000	52,600	10,000
May 17 2019	APTX	Aptinyx Inc.	Koppel Adam	Director	Option Exercise	A	3.73	40,000	149,200	40,000
Dec 17 2018	SLDB	Solid Biosciences ...	Koppel Adam	Director	Option Exercise	A	23.58	8,165	192,531	8,165
Jul 27 2018	SLDB	Solid Biosciences ...	Koppel Adam	Director	Option Exercise	A	37.89	1,835	69,528	1,835
Jun 26 2018	APTX	Aptinyx Inc.	Koppel Adam	Director	Option Exercise	C	0.00	50,347,397	0	0
Jun 26 2018	APTX	Aptinyx Inc.	Koppel Adam	Director	Buy	P	16.00	400,000	6,400,000	2,225,092	1.8 M to 2.2 M (+21.92 %)
Jun 26 2018	APTX	Aptinyx Inc.	Koppel Adam	Director	Buy	C	0.00	1,825,092	0	1,825,092	0 to 1.8 M
Jun 26 2018	APTX	Aptinyx Inc.	Koppel Adam	Director	Option Exercise	C	0.00	50,347,397	0	0
Jun 26 2018	APTX	Aptinyx Inc.	Koppel Adam	Director	Buy	P	16.00	400,000	6,400,000	2,225,092	1.8 M to 2.2 M (+21.92 %)
Jun 26 2018	APTX	Aptinyx Inc.	Koppel Adam	Director	Buy	C	0.00	1,825,092	0	1,825,092	0 to 1.8 M
Jun 25 2018	DRNA	Dicerna Pharmaceut ...	Koppel Adam	Director	Option Exercise	A	13.08	25,000	327,000	25,000
May 17 2018	TRVN	TREVENA INC	Koppel Adam	Director	Option Exercise	A	1.84	30,000	55,200	30,000
Feb 01 2018	SLDB	Solid Biosciences ...	Koppel Adam	Director	Option Exercise	M	0.00	1,991,097	0	0
Feb 01 2018	SLDB	Solid Biosciences ...	Koppel Adam	Director	Option Exercise	A	0.00	1,223,240	0	1,991,097
Feb 01 2018	SLDB	Solid Biosciences ...	Koppel Adam	Director	Buy	P	16.00	300,000	4,800,000	1,989,444	1.7 M to 2 M (+17.76 %)
Feb 01 2018	SLDB	Solid Biosciences ...	Koppel Adam	Director	Buy	M	0.00	1,689,444	0	1,689,444	0 to 1.7 M
Jul 20 2017	DRNA	Dicerna Pharmaceut ...	Koppel Adam	Director	Option Exercise	A	3.42	25,000	85,500	25,000
Jun 06 2017	TRVN	TREVENA INC	Koppel Adam	Director	Option Exercise	A	3.08	15,000	46,200	15,000
Apr 13 2017	DRNA	Dicerna Pharmaceut ...	Koppel Adam	Director	Option Exercise	A	3.47	25,000	86,750	25,000
Jan 05 2017	PTCT	PTC THERAPEUTICS, ...	Koppel Adam	Director	Option Exercise	A	11.23	12,000	134,760	12,000
Jun 07 2016	IDPH	BIOGEN INC.	Koppel Adam	EVP, Strategy and B ...	Sell	S	290.00	555	160,950	2,402	3 K to 2.4 K (-18.77 %)
Jun 06 2016	IDPH	BIOGEN INC.	Koppel Adam	EVP, Strategy and B ...	Option Exercise	J	0.00	1,969	0	3,616
Jun 06 2016	IDPH	BIOGEN INC.	Koppel Adam	EVP, Strategy and B ...	Option Exercise	M	0.00	1,643	0	5,585
Jun 06 2016	IDPH	BIOGEN INC.	Koppel Adam	EVP, Strategy and B ...	Payment of Exercise	F	289.73	534	154,716	2,957	3.5 K to 3 K (-15.30 %)
Jun 06 2016	IDPH	BIOGEN INC.	Koppel Adam	EVP, Strategy and B ...	Buy	M	0.00	1,643	0	3,491	1.8 K to 3.5 K (+88.91 %)
May 19 2016	TRVN	TREVENA INC	Koppel Adam	Director	Option Exercise	A	6.98	15,000	104,700	15,000
Apr 07 2016	IDPH	BIOGEN INC.	Koppel Adam	EVP, Strategy and B ...	Sell	S	275.00	102	28,050	1,848	2 K to 1.8 K (-5.23 %)
Feb 25 2016	IDPH	BIOGEN INC.	Koppel Adam	EVP, Strategy and B ...	Option Exercise	J	0.00	597	0	1,802
Feb 25 2016	IDPH	BIOGEN INC.	Koppel Adam	EVP, Strategy and B ...	Option Exercise	M	0.00	301	0	2,399
Feb 25 2016	IDPH	BIOGEN INC.	Koppel Adam	EVP, Strategy and B ...	Payment of Exercise	F	258.99	98	25,381	1,865	2 K to 1.9 K (-4.99 %)
Feb 25 2016	IDPH	BIOGEN INC.	Koppel Adam	EVP, Strategy and B ...	Buy	M	0.00	301	0	1,963	1.7 K to 2 K (+18.11 %)
Feb 24 2016	IDPH	BIOGEN INC.	Koppel Adam	EVP, Strategy and B ...	Option Exercise	A	0.00	7,270	0	7,270
Jan 06 2016	PTCT	PTC THERAPEUTICS, ...	Koppel Adam	Director	Option Exercise	A	30.86	12,000	370,320	12,000
Jun 04 2015	IDPH	BIOGEN INC.	Koppel Adam	SVP, Chief Strategy ...	Option Exercise	J	0.00	1,228	0	7,228
Jun 04 2015	IDPH	BIOGEN INC.	Koppel Adam	SVP, Chief Strategy ...	Option Exercise	M	0.00	2,384	0	8,456
Jun 04 2015	IDPH	BIOGEN INC.	Koppel Adam	SVP, Chief Strategy ...	Payment of Exercise	F	387.62	852	330,252	1,662	2.5 K to 1.7 K (-33.89 %)
Jun 04 2015	IDPH	BIOGEN INC.	Koppel Adam	SVP, Chief Strategy ...	Buy	M	0.00	2,384	0	2,514	130 to 2.5 K (+1,833.85 %)
May 21 2015	TRVN	TREVENA INC	Koppel Adam	Director	Option Exercise	A	6.80	8,870	60,316	8,870
Feb 25 2015	IDPH	BIOGEN INC.	Koppel Adam	SVP, Chief Strategy ...	Option Exercise	A	0.00	2,700	0	2,700
Jun 28 2013	PTCT	PTC THERAPEUTICS, ...	Koppel Adam	Director	Option Exercise	C	0.00	1,083,333	0	0
Jun 28 2013	PTCT	PTC THERAPEUTICS, ...	Koppel Adam	Director	Option Exercise	A	0.00	1,083,333	0	1,083,333
Jun 28 2013	PTCT	PTC THERAPEUTICS, ...	Koppel Adam	Director	Buy	P	15.00	1,250,000	18,750,000	2,333,333	1.1 M to 2.3 M (+115.38 %)
Jun 28 2013	PTCT	PTC THERAPEUTICS, ...	Koppel Adam	Director	Buy	C	0.00	1,083,333	0	1,083,333	0 to 1.1 M

Page: 1